Rating Change
Oppenheimer analysts reiterated a Outperform rating on Ligand Pharmaceuticals, Inc. (OTC:LGNZZ) on August 03, 2026.
reiterateOTC:LGNZZ
Oppenheimer Reiterates Outperform Rating on Ligand Pharmaceuticals, Inc. (LGNZZ)
Rating Change Oppenheimer analysts reiterated a Outperform rating on Ligand Pharmaceuticals, Inc. (OTC:LGNZZ) on August 03, 2026. Market Context Ligand Pharmaceuticals, Inc.
Market Context
Ligand Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $0.06 with a market capitalization of $1.4M.
Analyst coverage from Oppenheimer provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Ligand Pharmaceuticals, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Ligand Pharmaceuticals, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 03, 2026 | Oppenheimer | Outperform | N/A |
| Jul 21, 2026 | Citigroup | Buy | N/A |
| Jul 15, 2026 | RBC Capital | Outperform | N/A |
| Jul 09, 2026 | B of A Securities | Buy | N/A |
| Jul 08, 2026 | Stifel | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View LGNZZ Stock Page
Frequently Asked Questions
What does a Outperform rating mean for LGNZZ?
A Outperform rating from Oppenheimer reflects the analyst's outlook on Ligand Pharmaceuticals, Inc. (OTC:LGNZZ). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the LGNZZ forecast page.